AICD for improved heart rhythm management

AICD

AICD, or Automatic Implantable Cardioverter Defibrillator, is a device that monitors the heart continuously and can deliver life-saving therapy if dangerous fast rhythms develop.

How AICD Helps

  • The device detects malignant ventricular rhythms and responds quickly when needed.

  • It may provide pacing, anti-tachycardia therapy, or a protective shock depending on the event.

  • AICD selection depends on rhythm history, heart function, and sudden death risk.

  • Long-term review helps assess stored events, battery status, and treatment effectiveness.

Who May Need AICD

  • Patients with prior life-threatening ventricular rhythm disturbances.

  • People with severely reduced heart function and high sudden arrest risk.

  • Cases where medicine alone is not enough to provide long-term rhythm protection.

  • Patients with inherited or structural heart disease linked to dangerous fast rhythms.

What to Expect With AICD

  • Implantation is preceded by detailed evaluation of rhythm risk and heart muscle status.

  • Patients are guided about living with the device, shock awareness, and follow-up checks.

  • Routine device interrogation helps refine settings and monitor therapy delivery.

  • Ongoing care also includes medicine review and control of the underlying heart condition.

Benefits of AICD

  • Provides continuous support for heart rhythm or pumping function.

  • Reduces the risk of serious rhythm-related complications in suitable patients.

  • Improves confidence with regular monitoring, checks, and planned follow-up.

  • Supports better long-term heart performance and quality of life.

Book a AICD Consultation

Consult our cardiology team to understand whether AICD is appropriate for your condition. Timely evaluation helps identify the right device plan, improve safety, and support better long-term heart function.

Frequently Asked Questions

What is the role of AICD?

AICD, or Automatic Implantable Cardioverter Defibrillator, is a device that monitors the heart continuously and can deliver life-saving therapy if dangerous fast rhythms develop. The device detects malignant ventricular rhythms and responds quickly when needed. It may provide pacing, anti-tachycardia therapy, or a protective shock depending on the event. AICD selection depends on rhythm history, heart function, and sudden death risk. Long-term review helps assess stored events, battery status, and treatment effectiveness.

Who may need AICD?

Patients with prior life-threatening ventricular rhythm disturbances. People with severely reduced heart function and high sudden arrest risk. Cases where medicine alone is not enough to provide long-term rhythm protection. Patients with inherited or structural heart disease linked to dangerous fast rhythms.

What should patients expect with AICD?

Implantation is preceded by detailed evaluation of rhythm risk and heart muscle status. Patients are guided about living with the device, shock awareness, and follow-up checks. Routine device interrogation helps refine settings and monitor therapy delivery. Ongoing care also includes medicine review and control of the underlying heart condition.

What are the benefits of AICD?

Provides continuous support for heart rhythm or pumping function. Reduces the risk of serious rhythm-related complications in suitable patients. Improves confidence with regular monitoring, checks, and planned follow-up. Supports better long-term heart performance and quality of life.

Go Back Top